Recent Research Analysts’ Ratings Updates for DENTSPLY SIRONA (XRAY)

Share on StockTwits

A number of firms have modified their ratings and price targets on shares of DENTSPLY SIRONA (NASDAQ: XRAY) recently:

  • 11/15/2019 – DENTSPLY SIRONA had its “hold” rating reaffirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
  • 11/9/2019 – DENTSPLY SIRONA was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 11/8/2019 – DENTSPLY SIRONA had its price target raised by analysts at Barclays PLC from $55.00 to $58.00. They now have an “equal weight” rating on the stock.
  • 11/8/2019 – DENTSPLY SIRONA had its price target raised by analysts at Stifel Nicolaus from $61.00 to $63.00. They now have a “buy” rating on the stock.
  • 10/29/2019 – DENTSPLY SIRONA was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 10/8/2019 – DENTSPLY SIRONA was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 10/2/2019 – DENTSPLY SIRONA was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.
  • 9/24/2019 – DENTSPLY SIRONA was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating.

Shares of NASDAQ:XRAY traded up $0.53 during trading on Friday, reaching $56.56. The stock had a trading volume of 34,259 shares, compared to its average volume of 1,679,147. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The business has a fifty day moving average price of $54.40 and a 200-day moving average price of $54.36. The stock has a market cap of $12.49 billion, a PE ratio of 28.14, a PEG ratio of 1.97 and a beta of 0.96. DENTSPLY SIRONA Inc has a 1-year low of $34.93 and a 1-year high of $60.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.57 EPS for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.07. DENTSPLY SIRONA had a return on equity of 10.08% and a net margin of 4.08%. The firm had revenue of $962.10 million for the quarter, compared to the consensus estimate of $940.38 million. During the same quarter last year, the business posted $0.38 earnings per share. The firm’s revenue was up 3.6% compared to the same quarter last year. Sell-side analysts expect that DENTSPLY SIRONA Inc will post 2.46 earnings per share for the current year.

In related news, Director Michael C. Alfano sold 10,665 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $56.27, for a total transaction of $600,119.55. Following the transaction, the director now owns 15,153 shares in the company, valued at $852,659.31. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.62% of the company’s stock.

A number of institutional investors have recently made changes to their positions in XRAY. Altshuler Shaham Ltd lifted its position in DENTSPLY SIRONA by 209.8% during the second quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 342 shares in the last quarter. Quest Capital Management Inc. ADV purchased a new position in DENTSPLY SIRONA during the third quarter worth approximately $30,000. Rational Advisors LLC lifted its position in DENTSPLY SIRONA by 102.7% during the third quarter. Rational Advisors LLC now owns 675 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 342 shares in the last quarter. Cornerstone Advisors Inc. lifted its position in DENTSPLY SIRONA by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock worth $53,000 after buying an additional 346 shares in the last quarter. Finally, Van ECK Associates Corp purchased a new position in DENTSPLY SIRONA during the second quarter worth approximately $54,000. Hedge funds and other institutional investors own 92.93% of the company’s stock.

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Dividend Aristocrat Index

Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Spero Therapeutics Inc  Expected to Announce Earnings of -$1.04 Per Share
Spero Therapeutics Inc Expected to Announce Earnings of -$1.04 Per Share
Quanta Utility Token  Reaches Market Cap of $1.41 Million
Quanta Utility Token Reaches Market Cap of $1.41 Million
Storiqa 24-Hour Volume Tops $348.00
Storiqa 24-Hour Volume Tops $348.00
IQeon Trading 0.9% Higher  Over Last 7 Days
IQeon Trading 0.9% Higher Over Last 7 Days
Octoin Coin Price Tops $0.0067 on Exchanges
Octoin Coin Price Tops $0.0067 on Exchanges
Brokerages Expect Consolidated Edison, Inc.  Will Post Quarterly Sales of $3.04 Billion
Brokerages Expect Consolidated Edison, Inc. Will Post Quarterly Sales of $3.04 Billion


© 2006-2019 Ticker Report